glp-1 prescriptions q1 2025 growth Thinking about GLP-1s lately? In a new study, we analyzed ~1.4 million adults with sleep apnea from 2017–2025 and found: 🔹 6x increase in new 🔹14x increase in patients taking GLP-1 Receptor Agonist Market Size,

As it evolves its product line, Novo Nordisk is facing lawsuits at the state and federal levels, alleging that its GLP-1 drugs, like Wegovy, have caused serious injuries to some patients

T., Batterham, R

B.M.K.H., M.S.A., D.D., T.S., F.T.Z.A., L.N

Results of this and future studies could offer a promising new way to help reduce the risk of colorectal cancer before it develops

These medications can slow the emptying of the stomach, making people feel full longer, and suppress appetite by slowing hunger signals in the brain

MeAgain GLP-1 side effects hub Medical side-effect background and the cross-medication side-effect guide cluster.